Show source-provided references
1. World Health Organization (2024, March 14). WHO Launches New Roadmap on Breast Cancer. Available online: https://www.who.int/news/item/03-02-2023-who-launches-new-roadmap-on-breast-cancer#:~:text=There%20are%20more%20than%202.3,cause%20of%20female%20cancer%20deaths.
4. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
10.1172/JCI45014 ↗7. Laser-induced heating of polydimethylsiloxane-magnetite nanocomposites for hyperthermic inhibition of triple-negative breast cancer cell proliferation
10.1002/jbm.b.35124 ↗10. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
10.1038/nrd4333 ↗15. Magnetic Field Triggerable Macroporous PDMS Sponge Loaded with an Anticancer Drug, 5-Fluorouracil. ACS Biomater
17. Ma, P., Jiang, L., Luo, X., Chen, J., Wang, Q., Chen, Y., Ye, E., Loh, X.J., Wu, C., and Wu, Y.L. (2022). Hybrid Polydimethylsiloxane (PDMS) Incorporated Thermogelling System for Effective Liver Cancer Treatment. Pharmaceutics, 14.
10.3390/pharmaceutics14122623 ↗18. Direct Intranuclear Anticancer Drug Delivery via Polydimethylsiloxane Nanoparticles: In vitro and in vivo Xenograft Studies
10.1021/acsami.7b08806 ↗19. Bioactive nanotherapeutic trends to combat triple negative breast cancer
20. Targeted chemotherapy for triple-negative breast cancers via LHRH receptor
21. LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer
10.1038/s41598-020-64979-1 ↗22. Sanchez, A.M., Flamini, M.I., Zullino, S., Russo, E., Giannini, A., Mannella, P., Naccarato, A.G., Genazzani, A.R., and Simoncini, T. (2018). Regulatory actions of LH and follicle-stimulating hormone on breast cancer cells and mammary tumors in rats. Front. Endocrinol., 9.
10.3389/fendo.2018.00239 ↗23. Swelling of poly(N-isopropylacrylamide) P(NIPA)-based hydrogels with bacterial-synthesized prodigiosin for localized cancer drug delivery
10.1016/j.msec.2015.09.090 ↗24. Sustained release of alpha-methylacyl-CoA racemase (AMACR) antibody-conjugated and free doxorubicin from silica nanoparticles for prostate cancer cell growth inhibition
10.1002/jbm.b.35185 ↗26. Magnetite nanoparticle coated with amphiphilic bilayer surfactant of polysiloxane and poly(poly(ethylene glycol) methacrylate)
10.1007/s11051-012-0953-y ↗27. Poly(dimethylsiloxane) and poly[vinyltrimethoxysilane-co-2-(dimethylamino) ethyl methacrylate] based cross-linked organic-inorganic hybrid adsorbent for copper(II) removal from aqueous solutions
28. Johnson, L.M., Gao, L., Shields, W., Smith, M., Efimenko, K., Cushing, K., Genzer, J., and López, G.P. (2013). Elastomeric microparticles for acoustic mediated bioseparations. J. Nanobiotechnol., 11, Available online: http://www.jnanobiotechnology.com/content/11/1/22.
10.1186/1477-3155-11-22 ↗31. Polymeric nanoparticles containing diazepam: Preparation, optimization, characterization, in-vitro drug release and release kinetic study
10.1186/s40580-016-0061-2 ↗32. Jeronimo, K., Koutsos, V., Cheung, R., and Mastropaolo, E. (2021). PDMS-ZnO piezoelectric nanocomposites for pressure sensors. Sensors, 21.
10.3390/s21175873 ↗35. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems
10.1517/17425241003602259 ↗36. Effect of Temperature on Drug Release: Production of 5-FU-Encapsulated Hydroxyapatite-Gelatin Polymer Composites via Spray Drying and Analysis of in vitro Kinetics
10.1155/2020/8017035 ↗37. Effect of temperature-increase rate on drug release characteristics of dextran microspheres prepared by emulsion solvent evaporation process
10.1016/j.ijpharm.2006.06.003 ↗38. Drug release from thin films encapsulated by a temperature-responsive hydrogel
10.1039/C8SM02529K ↗39. In-vivo studies of targeted and localized cancer drug release from microporous poly-di-methyl-siloxane (PDMS) devices for the treatment of triple negative breast cancer
10.1038/s41598-023-50656-6 ↗40. National Center for Biotechnology Information (2024, June 24). PubChem Compound Summary for CID 136183466, Prodigiosin, Available online: https://pubchem.ncbi.nlm.nih.gov/compound/prodigiosin-R1.
44. Heredia, N.S., Vizuete, K., Flores-Calero, M., Pazmiño, V.K., Pilaquinga, F., Kumar, B., and Debut, A. (2022). Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly(lactic-co-glycolic acid). PLoS ONE, 17.
10.1371/journal.pone.0264825 ↗45. Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., and Shao, A. (2020). Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front. Mol. Biosci., 7.
10.3389/fmolb.2020.00193 ↗47. Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system
10.2147/IJN.S126245 ↗48. Bai, X., Smith, Z.L., Wang, Y., Butterworth, S., and Tirella, A. (2022). Sustained Drug Release from Smart Nanoparticles in Cancer Therapy: A Comprehensive Review. Micromachines, 13.
10.3390/mi13101623 ↗49. Adepu, S., and Ramakrishna, S. (2021). Controlled drug delivery systems: Current status and future directions. Molecules, 26.
10.3390/molecules26195905 ↗51. Targeted Drug Delivery—From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives
10.2147/JMDH.S313968 ↗52. Veselov, V.V., Nosyrev, A.E., Jicsinszky, L., Alyautdin, R.N., and Cravotto, G. (2022). Targeted Delivery Methods for Anticancer Drugs. Cancers, 14.
10.3390/cancers14030622 ↗54. Paclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT/MAPK signaling pathway in canine mammary gland tumor cells
57. Li, D., Liu, J., Wang, X., Kong, D., Du, W., Li, H., Hse, C.Y., Shupe, T., Zhou, D., and Zhao, K. (2018). Biological potential and mechanism of prodigiosin from Serratia marcescens subsp. Lawsoniana in human choriocarcinoma and prostate cancer cell lines. Int. J. Mol. Sci., 19.
10.3390/ijms19113465 ↗